These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15032183)

  • 41. Alzheimer's disease: will advances made in the past turn the tide?
    Semla TP
    Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
    [No Abstract]   [Full Text] [Related]  

  • 42. New drug treatment for Alzheimer's disease. Effects of drugs can be variable.
    Levy R
    BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9841008
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Donepezil in Alzheimer's disease and vascular dementia].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dementia.
    Warner J; Butler R; Wuntakal B
    Clin Evid; 2005 Dec; (14):1198-220. PubMed ID: 16620452
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New drug treatment for Alzheimer's disease. Drugs should not need to show cost effectiveness to justify their prescription.
    Evans M
    BMJ; 1998 Oct; 317(7163):945-6. PubMed ID: 9841009
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of donepezil in treating Alzheimer's disease.
    Garcia A
    Can Fam Physician; 1999 Aug; 45():1858-9. PubMed ID: 10463081
    [No Abstract]   [Full Text] [Related]  

  • 50. New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy.
    Dening T; Lawton C
    BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9756823
    [No Abstract]   [Full Text] [Related]  

  • 51. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The amnestic prodrome of Alzheimer's disease.
    Hodges J
    Brain; 1998 Sep; 121 ( Pt 9)():1601-2. PubMed ID: 9762951
    [No Abstract]   [Full Text] [Related]  

  • 53. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R
    Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
    Chen R; Chan PT; Chu H; Lin YC; Chang PC; Chen CY; Chou KR
    PLoS One; 2017; 12(8):e0183586. PubMed ID: 28827830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug may temporarily slow progression of mild cognitive impairment.
    Mayo Clin Womens Healthsource; 2005 Aug; 9(8):3. PubMed ID: 16015194
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
    Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.